Routine Laboratory Measures in the Controlled-Treatment Period of Phase III Ocrelizumab Trials in Relapsing and Progressive Multiple SclerosisJerry Wolinsky,Ludwig Kappos,Xavier Montalban,Cathy Chognot,Harold Koendgen,Carrie Li,Ashish Pradhan,Stephen HauserNEUROLOGY(2018)引用 2|浏览17暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要